JP2011502968A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502968A5
JP2011502968A5 JP2010531519A JP2010531519A JP2011502968A5 JP 2011502968 A5 JP2011502968 A5 JP 2011502968A5 JP 2010531519 A JP2010531519 A JP 2010531519A JP 2010531519 A JP2010531519 A JP 2010531519A JP 2011502968 A5 JP2011502968 A5 JP 2011502968A5
Authority
JP
Japan
Prior art keywords
preparation according
preparation
luteinizing hormone
concentration
hlh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010531519A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502968A (ja
JP5551601B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/064679 external-priority patent/WO2009056569A1/en
Publication of JP2011502968A publication Critical patent/JP2011502968A/ja
Publication of JP2011502968A5 publication Critical patent/JP2011502968A5/ja
Application granted granted Critical
Publication of JP5551601B2 publication Critical patent/JP5551601B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010531519A 2007-11-01 2008-10-29 Lh液体調製物 Active JP5551601B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP07119832.9 2007-11-01
EP07119832 2007-11-01
US448107P 2007-11-28 2007-11-28
US61/004,481 2007-11-28
PCT/EP2008/064679 WO2009056569A1 (en) 2007-11-01 2008-10-29 Lh liquid formulations

Publications (3)

Publication Number Publication Date
JP2011502968A JP2011502968A (ja) 2011-01-27
JP2011502968A5 true JP2011502968A5 (cg-RX-API-DMAC7.html) 2011-12-22
JP5551601B2 JP5551601B2 (ja) 2014-07-16

Family

ID=39167502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010531519A Active JP5551601B2 (ja) 2007-11-01 2008-10-29 Lh液体調製物

Country Status (25)

Country Link
US (1) US8664369B2 (cg-RX-API-DMAC7.html)
EP (1) EP2219607B1 (cg-RX-API-DMAC7.html)
JP (1) JP5551601B2 (cg-RX-API-DMAC7.html)
KR (1) KR101513181B1 (cg-RX-API-DMAC7.html)
CN (1) CN101842083B (cg-RX-API-DMAC7.html)
AU (1) AU2008320844B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0818324B8 (cg-RX-API-DMAC7.html)
CA (1) CA2700662C (cg-RX-API-DMAC7.html)
CY (1) CY1113121T1 (cg-RX-API-DMAC7.html)
DK (1) DK2219607T3 (cg-RX-API-DMAC7.html)
EA (1) EA019432B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP10010224A (cg-RX-API-DMAC7.html)
ES (1) ES2393233T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20120660T1 (cg-RX-API-DMAC7.html)
IL (1) IL205105A (cg-RX-API-DMAC7.html)
MX (1) MX2010004639A (cg-RX-API-DMAC7.html)
MY (1) MY153976A (cg-RX-API-DMAC7.html)
NZ (1) NZ583991A (cg-RX-API-DMAC7.html)
PL (1) PL2219607T3 (cg-RX-API-DMAC7.html)
PT (1) PT2219607E (cg-RX-API-DMAC7.html)
RS (1) RS52566B (cg-RX-API-DMAC7.html)
SI (1) SI2219607T1 (cg-RX-API-DMAC7.html)
UA (1) UA101484C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009056569A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201001907B (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY152979A (en) 2008-01-09 2014-12-15 Sanofi Aventis Deutschland Novel insulin derivatives having an extremely delayed time-action profile
PL3228320T3 (pl) 2008-10-17 2020-06-01 Sanofi-Aventis Deutschland Gmbh Kombinacja insuliny i agonisty GLP-1
JP2011001273A (ja) * 2009-06-16 2011-01-06 Eci Inc eMIPを有効成分とする水溶性製剤
TWI520745B (zh) * 2009-07-06 2016-02-11 賽諾菲阿凡提斯德意志有限公司 含甲硫胺酸之胰島素製劑
SI2498801T1 (en) 2009-11-13 2018-06-29 Sanofi-Aventis Deutschland Gmbh A pharmaceutical composition containing desPro36Exendin-4 (1-39) -Lys6-NH2 and methionine
CA3011480C (en) 2009-11-13 2021-11-09 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
RU2553375C2 (ru) * 2010-02-12 2015-06-10 Интас Биофармасьютикалс Лимитед Жидкий состав фолликулостимулирующего гормона
EP2611458B1 (en) 2010-08-30 2016-09-21 Sanofi-Aventis Deutschland GmbH Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN102293756A (zh) * 2011-08-24 2011-12-28 蚌埠丰原涂山制药有限公司 一种尿促性素冻干粉针剂及其制备方法
EP2750699B1 (en) 2011-08-29 2015-07-22 Sanofi-Aventis Deutschland GmbH Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
NZ707168A (en) * 2012-12-26 2016-09-30 Wockhardt Ltd Pharmaceutical composition of insulins
TWI780236B (zh) 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
EP2968391A1 (en) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
RU2016132342A (ru) 2014-01-09 2018-02-14 Санофи Стабилизированные фармацевтические составы на основе инсулиновых аналогов и/или инсулиновых производных
RU2016132340A (ru) 2014-01-09 2018-02-14 Санофи Стабилизированные фармацевтические составы на основе инсулина аспарта
CN105899191B (zh) 2014-01-09 2020-06-16 赛诺菲 胰岛素类似物和/或胰岛素衍生物的稳定化不含甘油的药物制剂
PE20171622A1 (es) 2014-12-12 2017-11-02 Sanofi Aventis Deutschland Formulacion de relacion fija de insulina glargina/lixisenatida
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
GB201603280D0 (en) * 2016-02-24 2016-04-13 Ferring Bv Stable liquid gonadotropin formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US5681302A (en) * 1994-06-14 1997-10-28 Minnesota Mining And Manufacturing Company Elastic sheet-like composite
UA61053C2 (en) * 1995-03-21 2003-11-17 Applied Research Systems Stable liquid pharmaceutical compositions, method for its production and delivery form
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
NZ508874A (en) * 1998-07-23 2004-03-26 Lilly Co Eli FSH and FSH variant formulations, products and methods of treating infertility.
EP1599222B1 (en) * 2003-01-08 2009-03-04 Novartis Vaccines and Diagnostics, Inc. Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant
US7387998B2 (en) 2003-03-28 2008-06-17 New York University STQ peptides
CA2518903C (en) * 2003-04-02 2013-02-05 Ares Trading S.A. Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant

Similar Documents

Publication Publication Date Title
JP2011502968A5 (cg-RX-API-DMAC7.html)
HRP20120660T1 (hr) Tekuće formulacije lh
HRP20200998T1 (hr) Postupak i sastav za liječenje okularne hipertenzije i glaukoma
FI4374878T3 (fi) Karbetosiinia käsittävä farmaseuttinen koostumus
JP2013543492A5 (cg-RX-API-DMAC7.html)
KR101940341B1 (ko) 약학 조성물
HRP20110801T1 (hr) Tekući oblik fsh
JP2015527402A5 (cg-RX-API-DMAC7.html)
TWI635874B (zh) 艾妥鈣塞(etelcalcetide)(amg 416)之穩定液體調配物
NO329930B1 (no) Farmasoytisk parenteral blanding inneholdende bifosfonat, et chelaterende middel og farmasoytisk akseptabelt tilsetningsmiddel, fremgangsmate for fremstilling av slike samt anordning for frigjoring inneholdende slike
HRP20191994T1 (hr) Formulacije ketorolaka spremne za uporabu
US20250195439A1 (en) Method for treating local lesion disease
HRP20110444T1 (hr) Formulacije paratiroidnih hormona i njihove uporabe
CN102821782B (zh) 促卵泡激素的液体配制品
BRPI0920973B1 (pt) composição aquosa contendo hormônio estimulanete de folículos
JP5149308B2 (ja) 局所的鼻腔投与のためのオロパタジンの製剤
KR20220116468A (ko) 펩티드 및 다당류의 새로운 접합체
CA2797658A1 (en) Casein peptide for use in the treatment of uterine infections
HRP20211696T1 (hr) Postupak izrade fluoriranih olefina
CN100553674C (zh) 一种重组人甲状旁腺激素(1-84)药物组合物及其制备方法
AR067047A1 (es) Formulaciones acuosas de acetaminofen para inyeccion.
RU2011134414A (ru) Комбинация фульвовой кислоты для лечения различных состояний и болезней
CN101972257B (zh) 一种含有莫西沙星的药物组合物
AR062894A1 (es) Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (ths)
CN101198350A (zh) 含胃动素样肽的稳定的缓冲的药物组合物